Royal Bank of Canada
BIOA

Royal Bank of Canada’s BioAge Labs BIOA Stock Holding History

Royal Bank of Canada’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-640
Closed -$9K – 7797
2025
Q4 		$9K Sell
640
-14,744
-96% -$131K ﹤0.01% 6493
2025
Q3 		$91K Buy
15,384
+12,843
+505% +$60.1K ﹤0.01% 5562
2025
Q2 		$11K Buy
2,541
+1,442
+131% +$5.81K ﹤0.01% 6463
2025
Q1 		$4K Sell
1,099
-74,809
-99% -$346K ﹤0.01% 6445
2024
Q4 		$440K Buy
+75,908
New +$1.31M ﹤0.01% 4175

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Royal Bank of Canada's BIOA Position: Q1 2026 in Review

Royal Bank of Canada sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 640 shares — an estimated $9K sold.

Royal Bank of Canada first reported a position in BIOA in Q4 2024 and held it in 5 quarters. The position peaked at $440K in Q4 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Royal Bank of Canada reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 640 BioAge Labs shares in Q1 2026, an estimated $9K.
  • Royal Bank of Canada first reported a position in BioAge Labs in Q4 2024 and held it in 5 quarters.
  • Royal Bank of Canada's BioAge Labs position peaked at $440K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.